Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Head and Neck Pathology|June 7, 2020
FET(EWSR1)-TFCP2 Rhabdomyosarcoma: An Additional Example of this Aggressive Variant with Predilection for the Gnathic BonesIoannis G Koutlas, Damon R Olson, Jawhar Rawwas
Acta Medica Portuguesa|February 20, 2026
Challenges with Congenital Lung Cysts: When to Consider DICER1 Testing? A Narrative ReviewGustavo Marcondes Rocha, Louis P Dehner, Damon R Olson, et al.
International Journal of Pediatric Otorhinolaryngology|March 5, 2018
Tracheal paraganglioma presenting as stridor in a pediatric patient, case report and literature reviewAmy L Dimachkieh, Allison Dobbie, Damon R Olson, et al.
Pediatric Blood & Cancer|September 29, 2020
Langerhans cell histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinibYoav H Messinger, Bruce C Bostrom, Damon R Olson, et al.
Archives of Pathology & Laboratory Medicine|March 26, 2021
Laboratory and Clinical Implications of Incidental and Secondary Germline Findings During Tumor TestingAllison Cushman-Vokoun, Josh Lauring, John Pfeifer, et al.
Archives of Pathology & Laboratory Medicine|December 12, 2022
Getting Your Laboratory on Track With Neurotrophic Receptor Tyrosine KinaseFrederick Inglis Rudolf Eyerer, Georganne Bradshaw, Patricia Vasalos, et al.
Archives of Pathology & Laboratory Medicine|May 10, 2026
Pleuropulmonary Blastoma and Diagnostic Pitfalls: A Report from the International Pleuropulmonary Blastoma/DICER1 RegistryAlexander T Nelson, Kris Ann P Schultz, Anne K Harris, et al.
NPJ Precision Oncology|July 9, 2025
RAS pathway targeted therapy in patients with DICER1-associated sarcomasLindy Zhang, Paige H R Mallinger, Serena Zhou, et al.
JCO Precision Oncology|April 23, 2025
Prognostic Significance of Germline DICER1 Pathogenic or Likely Pathogenic Variants in Outcomes of Ovarian Sertoli-Leydig Cell TumorAlexander T Nelson, Dave Watson, Kenneth S Chen, et al.
Pageof 2